MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,097,000 | -8.0% | 42,460 | -26.8% | 0.05% | -31.0% |
| Q3 2016 | $1,193,000 | -62.0% | 57,986 | -43.5% | 0.07% | -60.8% |
| Q2 2016 | $3,139,000 | +123.7% | 102,590 | +173.7% | 0.18% | +86.6% |
| Q1 2016 | $1,403,000 | -16.7% | 37,485 | -16.6% | 0.10% | -4.0% |
| Q3 2015 | $1,685,000 | +73.5% | 44,970 | +57.5% | 0.10% | +83.6% |
| Q2 2015 | $971,000 | -41.1% | 28,553 | -38.7% | 0.06% | -45.5% |
| Q1 2015 | $1,648,000 | -13.4% | 46,545 | -16.6% | 0.10% | -35.3% |
| Q4 2014 | $1,902,000 | -13.3% | 55,829 | -1.9% | 0.16% | +4.7% |
| Q3 2014 | $2,195,000 | +301.3% | 56,922 | +255.8% | 0.15% | +55.2% |
| Q1 2014 | $547,000 | -82.4% | 16,000 | -87.9% | 0.10% | -83.4% |
| Q3 2013 | $3,100,000 | +167.5% | 131,925 | +205.9% | 0.58% | +233.5% |
| Q2 2013 | $1,159,000 | – | 43,129 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |